Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Change in Accured Expenses (2016 - 2025)

Medifast's Change in Accured Expenses history spans 16 years, with the latest figure at -$4.3 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 61.65% year-over-year to -$4.3 million; the TTM value through Dec 2025 reached -$23.9 million, up 31.67%, while the annual FY2025 figure was -$23.9 million, 31.67% up from the prior year.
  • Change in Accured Expenses reached -$4.3 million in Q4 2025 per MED's latest filing, down from -$516000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $29.2 million in Q1 2021 to a low of -$21.9 million in Q1 2023.
  • Average Change in Accured Expenses over 5 years is -$3.9 million, with a median of -$5.2 million recorded in 2024.
  • Peak YoY movement for Change in Accured Expenses: surged 1582.14% in 2021, then tumbled 2982.14% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $11.6 million in 2021, then crashed by 231.82% to -$15.3 million in 2022, then skyrocketed by 97.63% to -$364000.0 in 2023, then crashed by 2982.14% to -$11.2 million in 2024, then surged by 61.65% to -$4.3 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Change in Accured Expenses are -$4.3 million (Q4 2025), -$516000.0 (Q3 2025), and -$13.1 million (Q2 2025).